Switch theme
Sign up to access all valuation multiples
Allianca Saude e Participacoes SA formerly Centro de Imagem Diagnosticos SA - Alliar is a diagnostic imaging company consisting of MRI machines, CT scanners and ultrasound machines. Its products include diagnostic medicine, diagnostic imaging and clinical analysis. The company is also engaged in the import of medical and hospital equipment, diagnosis kits, and related goods; Providing health consulting, advisory, courses and lectures.
2011
n/a
Last FY Revenue $224M
Last FY EBITDA $34.0M
$288M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Allianca Saude achieved revenue of $224M and an EBITDA of $34.0M.
Allianca Saude expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Allianca Saude valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $224M | XXX | XXX | XXX |
| Gross Profit | XXX | $65.4M | XXX | XXX | XXX |
| Gross Margin | XXX | 29% | XXX | XXX | XXX |
| EBITDA | XXX | $34.0M | XXX | XXX | XXX |
| EBITDA Margin | XXX | 15% | XXX | XXX | XXX |
| EBIT | XXX | $20.8M | XXX | XXX | XXX |
| EBIT Margin | XXX | 9% | XXX | XXX | XXX |
| Net Profit | XXX | -$23.8M | XXX | XXX | XXX |
| Net Margin | XXX | -11% | XXX | XXX | XXX |
| Net Debt | XXX | $112M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of August 18, 2025, Allianca Saude's stock price is BRL 5 (or $1).
Allianca Saude has current market cap of BRL 838M (or $154M), and EV of BRL 1.6B (or $288M).
See Allianca Saude trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $288M | $154M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of August 18, 2025, Allianca Saude has market cap of $154M and EV of $288M.
Allianca Saude's trades at 1.3x EV/Revenue multiple, and 8.5x EV/EBITDA.
Equity research analysts estimate Allianca Saude's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Allianca Saude's P/E ratio is not available.
See valuation multiples for Allianca Saude and 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $154M | XXX | $154M | XXX | XXX | XXX |
| EV (current) | $288M | XXX | $288M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 1.3x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 8.5x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | 13.8x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -6.5x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -11.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAllianca Saude's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
Allianca Saude's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Allianca Saude's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Allianca Saude and other 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 15% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 20% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Genesis Fertility Center | XXX | XXX | XXX | XXX | XXX | XXX |
| Dc Healthcare Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| Health Italia | XXX | XXX | XXX | XXX | XXX | XXX |
| Alignment Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Clover Health | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Allianca Saude acquired XXX companies to date.
Last acquisition by Allianca Saude was XXXXXXXX, XXXXX XXXXX XXXXXX . Allianca Saude acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free Trial| When was Allianca Saude founded? | Allianca Saude was founded in 2011. |
| Where is Allianca Saude headquartered? | Allianca Saude is headquartered in Brazil. |
| Is Allianca Saude publicy listed? | Yes, Allianca Saude is a public company listed on BVMF. |
| What is the stock symbol of Allianca Saude? | Allianca Saude trades under AALR3 ticker. |
| When did Allianca Saude go public? | Allianca Saude went public in 2016. |
| Who are competitors of Allianca Saude? | Similar companies to Allianca Saude include e.g. Genesis Fertility Center, Dc Healthcare Holdings, Health Italia, Alignment Healthcare. |
| What is the current market cap of Allianca Saude? | Allianca Saude's current market cap is $154M |
| Is Allianca Saude profitable? | Yes, Allianca Saude is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
